BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22271538)

  • 1. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.
    Ferguson RJ; McDonald BC; Rocque MA; Furstenberg CT; Horrigan S; Ahles TA; Saykin AJ
    Psychooncology; 2012 Feb; 21(2):176-86. PubMed ID: 22271538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
    Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioral management of chemotherapy-related cognitive change.
    Ferguson RJ; Ahles TA; Saykin AJ; McDonald BC; Furstenberg CT; Cole BF; Mott LA
    Psychooncology; 2007 Aug; 16(8):772-7. PubMed ID: 17152119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.
    Milbury K; Chaoul A; Biegler K; Wangyal T; Spelman A; Meyers CA; Arun B; Palmer JL; Taylor J; Cohen L
    Psychooncology; 2013 Oct; 22(10):2354-63. PubMed ID: 23657969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced cognitive training for breast cancer survivors: a randomized controlled trial.
    Von Ah D; Carpenter JS; Saykin A; Monahan P; Wu J; Yu M; Rebok G; Ball K; Schneider B; Weaver M; Tallman E; Unverzagt F
    Breast Cancer Res Treat; 2012 Oct; 135(3):799-809. PubMed ID: 22918524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors.
    Kesler S; Hadi Hosseini SM; Heckler C; Janelsins M; Palesh O; Mustian K; Morrow G
    Clin Breast Cancer; 2013 Aug; 13(4):299-306. PubMed ID: 23647804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in breast cancer survivors: a controlled comparison.
    Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
    Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance.
    Goedendorp MM; Knoop H; Gielissen MF; Verhagen CA; Bleijenberg G
    J Pain Symptom Manage; 2014 Jan; 47(1):35-44. PubMed ID: 23707383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of cognitive rehabilitation in cancer survivors.
    Cherrier MM; Anderson K; David D; Higano CS; Gray H; Church A; Willis SL
    Life Sci; 2013 Oct; 93(17):617-22. PubMed ID: 24012579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
    J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Web-based cognitive training for breast cancer survivors with cognitive complaints-a randomized controlled trial.
    Damholdt MF; Mehlsen M; O'Toole MS; Andreasen RK; Pedersen AD; Zachariae R
    Psychooncology; 2016 Nov; 25(11):1293-1300. PubMed ID: 26763774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
    Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
    Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
    Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.